Previous 10 | Next 10 |
Gainers: [[FSI]] +24.2%. [[AMRN]] +3.8%. [[CHWY]] +3.8%. [[EIGR]] +3.7%. [[AFI]] +3.6%.Losers: [[KC]] -8.9%. [[MRTN]] -7.9%. [[NTN]] -6.6%. [[SOS]] -5.5%. [[RLGY]] -4%. For further details see: AMRN, CHWY, RLGY and KC among after-hours movers
Shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) were skyrocketing 19% higher as of 3:10 p.m. EDT on Thursday. The big jump came after the company announced positive results from an investigator-sponsored clinical study evaluating peginterferon lambda (Lambda) in treating COVID-19 ...
Eiger BioPharmaceuticals (EIGR) jumps 17% premarket in after announcing results from the ILIAD (Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19) Study, an investigator sponsored randomized trial of Peginterferon Lambda (Lambda) in outpatients with mild to ...
The company announces results for its ILIAD Study (Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19), an investigator sponsored randomized trial of Peginterferon Lambda (Lambda) in outpatients with mild to moderate COVID-19 conducted at Toronto General Hosp...
Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19 - Lambda significantly accelerated viral decline - Viral clearance highl...
Shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) were sinking 18.9% lower as of 3:22 p.m. EDT on Monday. The big decline came after the company announced disappointing results from an investigator-sponsored clinical study evaluating Peginterferon Lambda-1a (Lambda) in treating outp...
Gainers: Genfit (GNFT) +35%, Trxade Group (MEDS) +20%, Celldex Therapeutics (CLDX) +15%, EDAP TMS (EDAP) +13%, Kaleido Biosciences (KLDO) +8%.Losers: Abeona Therapeutics (ABEO) -33%, Aquestive Therapeutics (AQST) -35%, Mallinckrodt (MNK)&...
Eiger BioPharmaceuticals (EIGR) slips 10% premarket on light volume in reaction to results from an investigator-sponsored study evaluating Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.Lambda, currently in late-stage development for hepatitis d...
Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19 PR Newswire PALO ALTO, Calif., Sept. 28, 2020 PALO ALTO, Calif. , Sept. 28, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), fo...
Short-term catalyst is the near-certain approval of lonafarnib in HGPS. No commercial value in HGPS, but lonafarnib MoA sets stage for fast tracking HDV candidate. Our semi automated TPT scoring system gives a score of above 70, making EIGR a buy. For further details see: ...
News, Short Squeeze, Breakout and More Instantly...
Eiger BioPharmaceuticals Inc. Company Name:
EIGR Stock Symbol:
NASDAQ Market:
Eiger BioPharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 6.5% to $0.95 on volume of 182,734,103 shares WiSA Technologies Inc. (WISA) fell 3.3% to $0.0235 on volume of 160,634,740 shares PROSHARES TRUST (SQQQ) rose 4.7% to $11.12 on volume of 151,373,755 shares...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 76.0% to $0.1065 on volume of 290,483,542 shares CXApp Inc. (CXAI) rose 151.0% to $6.15 on volume of 236,739,031 shares Nikola Corporation (NKLA) fell 1.0% to $1.03 on volume of 123,276,764 shares ...
Announces “Stalking Horse” Agreement for the Sale of Zokinvy ® (lonafarnib) Patient Access to Zokinvy ® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today ...